Research antibodies refer to antibodies that are used for research applications in the field of life sciences including drug discovery, genomics, and proteomics. Some of the major applications of research antibodies include immunohistochemistry, western blot, ELISA, flow cytometry and immunofluorescence. The increasing government and private funding for life sciences research as well as growing focus on developing innovative biologics have been driving the demand for research antibodies.
Global research antibodies market is estimated to be valued at USD 11.91 Bn in 2024 and is expected to reach USD 18.60 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.
Key Takeaways
Key players operating in the research antibodies market include Thermo Fisher Scientific, Inc., Merck KGaA (including Sigma-Aldrich), Abcam plc, Cell Signaling Technology, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Lonza Group AG, GenScript Biotech Corporation, BioLegend, Inc., Bio-Techne Corporation, F. Hoffmann-La Roche Ltd, Santa Cruz Biotechnology, Inc., BD Biosciences (Becton, Dickinson and Company), PerkinElmer, Inc., Active Motif, QIAGEN N.V., OriGene Technologies, Inc., Jackson ImmunoResearch Laboratories, Inc., RandD Systems (part of Bio-Teachne Corporation), Proteintech Group, Inc.The key players are focusing on expanding their geographic presence through strategic acquisitions and collaborations with regional players. Additionally, these companies are investing in development of new antibodies for a wider range of applications.
Furthermore, increasing research activity in Asia Pacific and Middle East & Africa regions is expected to offer significant growth opportunities for players in the Research Antibodies Market Demand over the forecast period.
Market Drivers and Restraints
The key drivers augmenting the growth of research antibodies market include increasing R&D investments in drug discovery as well as growing number of contract research organizations. According to estimates, global pharmaceutical R&D spending grew at a CAGR of 3.8% from 2015 to 2020 and is expected to surpass US$ 200 Bn by 2024. Additionally, rising prevalence of chronic and infectious diseases is another factor boosting research activities, thereby driving the demand for research antibodies. Moreover, technological advancements in antibody production technologies such as hybridoma technology and recombinant antibody production are also fueling the market growth.
However, high production costs associated with research-grade antibodies as well as stringent regulatory requirements are some of the factors inhibiting the market growth. Variations in antibody performance depending on source and production methods also pose a challenge. Additionally, limited translational capability from research to clinical applications is restraining the wider adoption of research antibodies in therapeutics space.
Segment Analysis
This market has different segments such as Primary Antibodies and Secondary Antibodies. Primary Antibodies is dominating segment with around 60% share as they are directly used in research to detect and analyze the structure and function of biomolecules such as proteins and genes. They directly bind to an antigen to mark it for analysis or visualization. They are highly specific and sensitive in nature which makes them preferable for western blots, immunofluorescence, immunohistochemistry, and other research techniques.
Global Analysis
North America region dominates the Research Antibodies Market Regional Analysis with the largest share due to continuous research activities in pharmaceutical and biotechnology companies in countries like United States. United States contributes around 75% share in North American research antibodies market owing to strategic presence of major pharmaceutical companies and research institutions conducting research activities.
Asia Pacific region is fastest growing market for research antibodies due to expansion of research facilities, funding, rising knowledge about personalized medicine. China and India contribute significantly to the regional market growth due to low-cost operations and availability of skilled labors.
Get More Insights On- Research Antibodies Market
Discover the language that resonates with you:
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
